I-MAT, NCT04291885: Immunotherapy Adjuvant Trial in Patients with Stage I-III Merkel Cell Carcinoma |
|
|
| Recruiting | 2 | 120 | RoW | Avelumab, anti-PD-L1, Bavencio, Placebo | Melanoma and Skin Cancer Trials Limited | Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II, Merkel Cell Carcinoma, Stage III, Neuroendocrine Tumors, Carcinoma Neuroendocrine Skin | 04/27 | 04/30 | | |